US Patent 10913712 Tetracycline compounds
Patent 10913712 was granted and assigned to Tetraphase Pharmaceuticals on February, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
April 24, 2019
Date of Patent
February 9, 2021
Patent Applicant
Patent Application Number
16393725
Patent Citations Received
Patent Inventor Names
Xiao-Yi Xiao
0
Minsheng He
0
Roger B. Clark
0
Wu-Yan Zhang
0
Cuixiang Sun
0
Diana Katharine Hunt
0
Magnus P. Ronn
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10913712 Tetracycline compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.